Lv4
490 积分 2025-11-02 加入
Complex and high-risk intervention in indicated patients (CHIP) in contemporary clinical practice
1天前
待确认
SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease
1天前
待确认
Understanding long-term risk in Percutaneous Coronary Intervention (PCI) in the Australian contemporary era with a focus on defining Complex Revascularisation in High-Risk Indicated Patients (CHIP)
1天前
待确认
CHIP‐PCI: Ready for a prime time?
1天前
待确认
CHIP fellowships: Carving a path for complex PCI
1天前
待确认
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial
1个月前
已完结
皖公网安备34019202002308
